Novartis Services, Inc.
Registered Principal Details
Business Or Interest:
All matters affecting pharmaceutical manufacturing and health care.
Lobbying Interests:
Mental health issues; drug pricing issues; health care reform; access; coverage; budgets.
CEO Name:
Vas Narasimhan
All matters affecting pharmaceutical manufacturing and health care.
Lobbying Interests:
Mental health issues; drug pricing issues; health care reform; access; coverage; budgets.
CEO Name:
Vas Narasimhan
Contact
CF
Candice Finnegan
801 Pennsylvania Ave. N.W., Suite 700
Washington, DC 20004
(908) 210-1962
candie.finnegan@novartis.com
http://www.novartis.com
801 Pennsylvania Ave. N.W., Suite 700
Washington, DC 20004
(908) 210-1962
candie.finnegan@novartis.com
http://www.novartis.com
Authorized Lobbyists
Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
---|---|---|---|
Dee George | Exclusive Duties No | Authorized On 12/30/2020 | Withdrawn On N/A |
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 744
Relating to: rare disease advisory council. (FE)
Bill Text and History
1/12/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: rare disease advisory council. (FE)
Bill Text and History
For
Notification Date1/12/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 689
Relating to: rare disease advisory council. (FE)
Bill Text and History
11/19/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: rare disease advisory council. (FE)
Bill Text and History
For
Notification Date11/19/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total | |
---|---|---|---|---|---|
Total Lobbying Expenditures | 2021 January - June $0.00 |
2021 July - December $0.00 |
2022 January - June $2,412.00 |
2022 July - December $0.00 |
Total $2,412.00 |
Total Hours Communicating | 2021 January - June 0.00 |
2021 July - December 0.00 |
2022 January - June 0.00 |
2022 July - December 0.00 |
Total 0.00 |
Total Hours Other | 2021 January - June 0.00 |
2021 July - December 0.00 |
2022 January - June 6.00 |
2022 July - December 0.00 |
Total 6.00 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
No legislative bills/resolutions found.
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
No topics found.
Minor Efforts
(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication